Source: Mercer National Survey of Employer-Sponsored Health Plans. Percentages sum to 101% due to rounding. (41% of large employers cover GLP-1 drugs for treatment of obesity, 59% do not). Note that employers used in this survey were defined as large employers having 500 or more employees.